Recombinant Bacteroides thetaiotaomicron UDP-N-acetylglucosamine--N-acetylmuramyl- (pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase (murG)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, provided as a reference for customers.
Shelf Life
Shelf life depends on storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during the production process. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
murG; BT_3448; UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase; EC 2.4.1.227; Undecaprenyl-PP-MurNAc-pentapeptide-UDPGlcNAc GlcNAc transferase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-372
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Bacteroides thetaiotaomicron (strain ATCC 29148 / DSM 2079 / NCTC 10582 / E50 / VPI-5482)
Target Names
murG
Target Protein Sequence
MEKELRIIIS GGGTGGHIFP AVSIANAIIE LRPDAKILFV GAEGRMEMQR VPDAGYKIIG LPIAGFDRKH LWKNVSVLIK LARSQWKARS IIKNFRPQVA VGVGGYASGP TLKTAGMMGV PTLIQEQNSY AGVTNKLLAQ KAKAICVAYD GMEKFFPADK IIMTGNPVRQ NLTKDMPEKG AALRSFNLQP DKKTILIVGG SLGARTINNT LTAALATIKE NNDIQFIWQT GKYYYPQVTE AVRAAGELPN LYVTDFIKDM AAAYAASDLV ISRAGAGSIS EFCLLHKPVV LVPSPNVAED HQTKNALALV DKQAAIYVKD SEAEAKLMDV ALNTVADDRK LKELSENIAK LALPDSARII AQEVIKLAEA EN
Uniprot No.

Target Background

Function
Function: Cell wall formation. This protein catalyzes the transfer of a GlcNAc subunit onto undecaprenyl-pyrophosphoryl-MurNAc-pentapeptide (lipid intermediate I) to form undecaprenyl-pyrophosphoryl-MurNAc-(pentapeptide)GlcNAc (lipid intermediate II).
Database Links

KEGG: bth:BT_3448

STRING: 226186.BT_3448

Protein Families
Glycosyltransferase 28 family, MurG subfamily
Subcellular Location
Cell inner membrane; Peripheral membrane protein; Cytoplasmic side.

Q&A

What is the function of MurG in Bacteroides thetaiotaomicron cell wall biosynthesis?

MurG functions as a glycosyltransferase that catalyzes a critical step in peptidoglycan biosynthesis, specifically transferring N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to lipid-linked N-acetylmuramyl-(pentapeptide) (Lipid I) to form Lipid II. This reaction represents an essential step in bacterial cell wall assembly, similar to the initial committed step catalyzed by MurA which transfers an enolpyruvyl group from phosphoenolpyruvate (PEP) to UDP-N-acetylglucosamine . In B. thetaiotaomicron, peptidoglycan synthesis is particularly important as this organism must maintain cell wall integrity while colonizing the competitive environment of the mammalian gut . The pathway is coordinated with other metabolic processes via master regulators such as BT4338, which controls hundreds of genes involved in carbohydrate utilization and gut colonization .

How does B. thetaiotaomicron MurG structure compare with orthologs from other bacterial species?

While the search results don't provide specific structural comparisons of B. thetaiotaomicron MurG with orthologs from other bacteria, research approaches to this question typically involve sequence alignment, structural modeling, and experimental validation. The methodology would include:

  • Multiple sequence alignment of MurG sequences from diverse bacterial species

  • Homology modeling based on available crystal structures (typically from E. coli)

  • Identification of conserved catalytic domains and species-specific variations

  • Expression and purification of recombinant proteins for structural studies

This approach is similar to that used for studying MurA enzymes, where multiple forms have been characterized across bacterial species, as demonstrated with the two active forms of UDP-N-acetylglucosamine enolpyruvyl transferase identified in S. pneumoniae .

What is the genetic context of the murG gene in B. thetaiotaomicron?

The murG gene in B. thetaiotaomicron exists within the context of cell wall biosynthesis genes. While the search results don't provide the specific genetic organization for murG, we can infer from related research that:

  • Cell wall biosynthesis genes are often organized in operons or gene clusters

  • Regulation may involve the master transcriptional regulator BT4338, which has been shown to bind to 834 locations in the B. thetaiotaomicron genome

  • The genetic organization would likely reflect the sequential steps in peptidoglycan synthesis

For experimental determination of the genetic context:

  • Whole genome sequencing and annotation

  • Transcriptional analysis to identify co-regulated genes

  • ChIP-seq analysis similar to that performed for BT4338 to identify regulatory elements

What are the optimal methods for cloning and expressing recombinant B. thetaiotaomicron MurG?

Based on successful approaches with other B. thetaiotaomicron proteins, the following methodology is recommended:

Cloning Strategy:

  • Amplify the murG gene using PCR from B. thetaiotaomicron genomic DNA with appropriate restriction sites incorporated into the primers

  • Clone the gene into expression vectors compatible with either E. coli or B. thetaiotaomicron expression systems

  • For B. thetaiotaomicron expression, utilize vectors such as pNBU2_erm with appropriate promoters like P BFP5E4

Expression Systems:

  • E. coli BL21(DE3) for initial expression attempts (similar to that used for MurA proteins)

  • Native expression in B. thetaiotaomicron using recently developed genetic tools

Purification Protocol:

  • Affinity chromatography using His-tag or other fusion tags

  • Ion-exchange chromatography for further purification

  • Size-exclusion chromatography for final polishing

This approach is supported by successful expression of related proteins such as MurA variants from S. pneumoniae, where the genes were amplified, cloned into appropriate vectors, and expressed in E. coli .

How can genetic manipulation techniques be optimized for B. thetaiotaomicron MurG studies?

Recent advances in genetic tools for B. thetaiotaomicron enable sophisticated manipulations for MurG studies:

Targeted Gene Modification:

  • Utilize the robust and efficient strategy for targeted genetic manipulation of diverse wild-type Bacteroides species described in the literature

  • For gene deletions or modifications, apply the two-step recombination process with efficiency assessment after each step:

    • First recombination: Integrate plasmid through homologous recombination

    • Second recombination: Remove plasmid backbone leaving the desired modification

Complementation Studies:

  • Use integration plasmids like pNBU2_erm for stable complementation

  • For promoter selection, consider the P BFP5E4 promoter which has been successfully used in previous studies

Efficiency Assessment:
For quantifying recombination efficiency:

  • First recombination: Plate serial dilutions on selective media and calculate CFU

  • Second recombination: Grow confirmed merodiploids and plate on appropriate selective media

What enzymatic assay methods are most reliable for characterizing recombinant B. thetaiotaomicron MurG activity?

While specific MurG assays aren't detailed in the search results, we can draw from methodologies used for related enzymes:

In vitro Enzymatic Assays:

  • Radiometric assay using 14C-labeled UDP-GlcNAc to measure transfer to Lipid I

  • HPLC-based assay to monitor substrate depletion and product formation

  • Coupled enzyme assays linking MurG activity to a measurable output

Activity Parameters to Measure:

  • Kinetic parameters (Km, Vmax, kcat)

  • Substrate specificity

  • Cofactor requirements

  • pH and temperature optima

Controls and Validations:

  • Include positive controls with well-characterized MurG from model organisms

  • Perform substrate and enzyme concentration-dependent assays

  • Verify product formation through mass spectrometry

Similar approaches have been used for characterizing MurA enzymes, where catalytic parameters were determined and inhibition by antibiotics like fosfomycin was assessed .

How can recombinant B. thetaiotaomicron MurG be used to screen for novel antimicrobial compounds?

MurG represents an attractive target for antimicrobial development due to its essential role in bacterial cell wall biosynthesis. A comprehensive screening methodology includes:

High-Throughput Screening Protocol:

  • Develop a miniaturized MurG activity assay adaptable to 96 or 384-well format

  • Screen compound libraries against purified recombinant MurG

  • Validate hits using secondary assays including:

    • Dose-response determinations

    • Specificity testing against other glycosyltransferases

    • Microbial growth inhibition assays

Structure-Activity Relationship Studies:

  • Analyze binding modes of lead compounds using computational docking

  • Synthesize derivatives to optimize activity and selectivity

  • Assess activity against MurG orthologs from pathogenic bacteria

In vivo Validation:

  • Test compounds in B. thetaiotaomicron growth assays

  • Assess impact on cell wall integrity using microscopy and biochemical assays

  • Evaluate effects in gut colonization models

This approach parallels studies with MurA inhibitors like fosfomycin, which has been shown to inhibit MurA enzymes that catalyze the first committed step in bacterial cell wall biosynthesis .

What strategies can be employed to investigate the regulation of MurG expression in B. thetaiotaomicron?

To investigate MurG regulation in B. thetaiotaomicron, researchers can employ several complementary approaches:

Transcriptional Regulation Analysis:

  • Perform RNA-seq under various growth conditions to identify factors affecting murG expression

  • Use ChIP-seq to identify transcription factors binding to the murG promoter region, similar to studies with BT4338

  • Construct reporter gene fusions to quantify promoter activity under different conditions

Regulatory Network Mapping:

  • Determine if murG is part of the BT4338 regulon, which controls hundreds of genes in B. thetaiotaomicron

  • Identify other transcription factors that might coordinate cell wall biosynthesis with carbohydrate metabolism

  • Analyze the role of translation factors like FusA2, which has been shown to be regulated by BT4338 and essential for gut colonization

Post-Transcriptional Regulation:

  • Investigate potential small RNA regulation of murG expression

  • Examine protein stability and turnover rates under different growth conditions

  • Assess the impact of translation efficiency on MurG protein levels

These approaches are informed by research on the BT4338 regulator, which has been shown to control both carbohydrate utilization and gut colonization through direct transcriptional activation of genes like fusA2 .

How does the functionality of recombinant B. thetaiotaomicron MurG compare in different expression systems?

Evaluating MurG functionality across expression systems involves systematic comparison:

Comparative Expression Analysis:

Expression SystemProtein YieldSolubilityEnzymatic ActivityPost-translational ModificationsAdvantagesLimitations
E. coliHighVariableMay be reducedMinimalEasy genetic manipulation, rapid growthPotential improper folding, inclusion bodies
B. thetaiotaomicronModerateGoodNative-likeNativeAuthentic processing, foldingComplex cultivation requirements, anaerobic conditions
Cell-free systemsVariableGoodVariableCustomizableRapid prototyping, toxic protein productionScalability issues, cost

Functionality Assessment Methodology:

  • Express MurG in multiple systems under standardized conditions

  • Purify using identical protocols where possible

  • Compare enzymatic parameters:

    • Specific activity

    • Substrate affinity

    • Stability

    • Inhibitor sensitivity

  • Assess structural integrity through circular dichroism and thermal shift assays

This approach is supported by studies on other B. thetaiotaomicron proteins, which have been successfully expressed using genetic tools developed specifically for this organism .

What are the common challenges in achieving stable expression of recombinant B. thetaiotaomicron MurG and how can they be addressed?

Researchers commonly encounter several challenges when working with recombinant B. thetaiotaomicron MurG:

Expression Challenges and Solutions:

  • Low expression levels:

    • Optimize codon usage for the expression host

    • Test multiple promoter systems (e.g., P BFP5E4 for B. thetaiotaomicron)

    • Adjust induction conditions (temperature, inducer concentration, time)

  • Protein insolubility:

    • Express as fusion with solubility-enhancing tags (MBP, SUMO)

    • Reduce expression temperature to slow folding

    • Supplement growth media with osmolytes or chaperone co-expression

  • Protein instability:

    • Include protease inhibitors during purification

    • Optimize buffer conditions (pH, salt, glycerol)

    • Store protein with stabilizing agents

  • Anaerobic expression requirements:

    • Utilize specialized anaerobic growth chambers for B. thetaiotaomicron cultivation

    • Develop oxygen-tolerant expression systems

    • Use consecutive batch culture (CBC) systems for maintaining anaerobic conditions

These approaches are informed by successful strategies used for other challenging Bacteroides proteins, as well as experiences with anaerobic cultivation systems for B. thetaiotaomicron .

How can researchers overcome difficulties in achieving functional activity of recombinant B. thetaiotaomicron MurG?

When facing issues with MurG enzymatic activity, researchers should consider:

Activity Restoration Strategies:

  • Cofactor supplementation:

    • Test addition of divalent cations (Mg2+, Mn2+)

    • Include reducing agents to maintain cysteine residues

    • Add stabilizing molecules like glycerol or specific lipids

  • Substrate quality:

    • Ensure purity of UDP-GlcNAc and Lipid I substrates

    • Verify substrate integrity through analytical methods

    • Consider synthesizing fresh substrates if activity is still problematic

  • Assay optimization:

    • Adjust buffer conditions systematically (pH, ionic strength)

    • Optimize enzyme and substrate concentrations

    • Evaluate different detection methods for higher sensitivity

  • Post-translational considerations:

    • Investigate if B. thetaiotaomicron MurG requires specific modifications

    • Co-express with potential partner proteins if applicable

    • Consider membrane association requirements

These approaches parallel troubleshooting strategies used for other bacterial glycosyltransferases and cell wall biosynthesis enzymes .

What statistical methods are most appropriate for analyzing kinetic data from recombinant B. thetaiotaomicron MurG experiments?

Statistical Analysis Framework:

  • Enzyme Kinetic Parameter Determination:

    • Use non-linear regression to fit Michaelis-Menten, Hill, or other appropriate kinetic models

    • Calculate confidence intervals for Km, Vmax, and other parameters

    • Employ Eadie-Hofstee or Lineweaver-Burk plots for visualization but not for primary parameter estimation

  • Inhibition Studies Analysis:

    • Determine inhibition constants (Ki) using appropriate models (competitive, non-competitive, uncompetitive)

    • Use global fitting for complex inhibition mechanisms

    • Calculate IC50 values and their confidence intervals

  • Comparative Analysis:

    • Apply ANOVA for comparing MurG variants or conditions

    • Use post-hoc tests (Tukey, Bonferroni) for multiple comparisons

    • Implement mixed-effects models for experiments with multiple variables

  • Data Validation:

    • Conduct residual analysis to verify model assumptions

    • Perform sensitivity analysis to identify influential data points

    • Use bootstrapping for robust parameter estimation when assumptions are violated

Similar statistical approaches have been applied to analyze kinetic parameters of related enzymes like MurA from different bacterial species .

How can recombinant B. thetaiotaomicron MurG be used to study host-microbe interactions in the gut?

Recombinant MurG can provide insights into host-microbe interactions through several experimental approaches:

Host-Microbe Interaction Studies:

  • Peptidoglycan recognition:

    • Investigate how modifications in MurG activity affect peptidoglycan structure

    • Study how these modifications impact recognition by host pattern recognition receptors

    • Analyze subsequent immune responses in vitro and in vivo

  • Colonization dynamics:

    • Create MurG variants with altered activity and assess their impact on gut colonization

    • Compare with other cell wall modification enzymes to determine relative importance

    • Monitor competitive fitness in the presence of other microbiota members

  • Cross-feeding interactions:

    • Investigate if peptidoglycan fragments serve as signaling molecules between bacteria

    • Study potential metabolic interactions involving cell wall components

    • Assess impact on community structure in complex microbial communities

These approaches build upon previous findings that B. thetaiotaomicron plays important roles in attenuating gut inflammation and enhancing innate immunity against pathogen invasion .

What considerations should researchers take into account when engineering B. thetaiotaomicron MurG for gut microbiome applications?

When engineering MurG for microbiome applications, researchers should consider:

Engineering Considerations:

  • Genetic stability:

    • Ensure stable integration of modified murG genes using appropriate vectors

    • Verify long-term retention in the absence of selection pressure

    • Monitor for potential horizontal gene transfer

  • Ecological impact:

    • Assess competitive fitness of engineered strains in complex communities

    • Evaluate potential disruption of microbiome homeostasis

    • Consider containment strategies for genetically modified organisms

  • Host response:

    • Investigate immunogenicity of modified cell wall structures

    • Evaluate potential for adverse inflammatory responses

    • Consider strain-specific variations in host-microbe interactions

  • Regulatory considerations:

    • Address biosafety concerns for genetically modified B. thetaiotaomicron

    • Consider biocontainment strategies such as auxotrophic dependencies

    • Design with potential therapeutic applications and regulatory requirements in mind

These considerations align with current perspectives on engineering B. thetaiotaomicron for synthetic biology applications, as discussed in recent reviews of the expanding genetic toolkit for this important gut commensal .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.